Announced
Synopsis
The Lubrizol acquires Bavaria Medizin Technologie, an innovative designer, and manufacturer of intravascular and nonvascular devices by its German subsidiary Lubrizol Deutschland from its current majority shareholder Custos Vermögensverwaltungs as well as from the minority shareholders. Financial terms were not disclosed. The acquisition of BMT expands Lubrizol’s product design, development, and manufacturing expertise and provides access to proprietary catheter and balloon technologies. “Lubrizol continues to invest in opportunities that position us as a full-service development partner for innovative OEMs in the interventional space,” Uwe Winzen, General Manager of Lubrizol LifeSciences.
Show Details & Financials
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.